Bayer response to lice study
This article was originally published in The Tan Sheet
Executive Summary
Conclusions on efficacy of Rid pediculicide cannot be drawn from recent in vitro study because University of Miami researchers "completely ignored" directions for use, Bayer says. Study in February Archives of Dermatology reported on kill rates of head lice exposed to cotton disks impregnated with OTC, Rx pediculicides (1"The Tan Sheet" March 4, 2002, p. 10). "Contrary to the method used in the study, Rid must be applied twice in a 10-day period, followed by combing on each occasion," Bayer says. "During each application lice are completely covered with Rid. The technique of placing lice on filter paper soaked with Rid, used in this study, would not be effective"...
You may also be interested in...
Pediculicide Formulation, Vehicle Differences Cited In Efficacy Study
The "large difference of efficacy" between two OTC pyrethrin products in a recent study is due to formulation and vehicle disparities in the lice remedies, researchers say in the February Archives of Dermatology
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.